In this episode, Medicom’s correspondent covers the highlights from the Dutch Dermatology Days (DDD 2023), held in Ermelo, the Netherlands, from 09-10 March 2023.
The topics discussed are:
- The role of surgeons in stage I–II melanoma
- When to screen for anal intraepithelial neoplasia?
- Eligibility and selection of JAK inhibitors for constitutional eczema
- JAK inhibitors for alopecia areata
- OCT non-inferior to biopsy in BCC
- Scabies: therapy failure and tips for the clinic
Enjoy listening!
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« ACC 2023 Highlights Podcast Next Article
AAD 2023 Highlights Podcast »
« ACC 2023 Highlights Podcast Next Article
AAD 2023 Highlights Podcast »
Table of Contents: DDD 2023
Featured articles
Dermato-Oncology
The role of surgeons in stage I–II melanoma
Melanoma: Surveillance and follow-up
When to screen for anal intraepithelial neoplasia?
JAK Inhibitors
Eligibility and selection of JAK inhibitors for constitutional eczema
Nutrition and the Skin
Obesity and the skin: state of affairs
What's New?
The importance of anti-microbial proteins in the skin
OCT non-inferior to biopsy in basal cell carcinoma
Infections
Scabies: Therapy failure and tips for the clinic
Related Articles
May 10, 2023
When to screen for anal intraepithelial neoplasia?
March 27, 2023
DDD 2023 Highlights Podcast
May 10, 2023
Skin diseases and nutrition
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com